34 malaria cases recorded in Ernakulam over past two months

Ernakulam has reported over 30 confirmed cases of malaria since April 1, 2025.
The total number of confirmed cases as on June 13 was 34. Of these, 21 cases were reported between May 1 and June 13. In April, as many as 13 confirmed cases were reported from various parts of the district, according to official data available with the Department of Health.
A majority of them were cases of indigenous malaria caused by Plasmodium vivax, considered less dangerous than the Plasmodium falciparum species. Most cases were imported (malaria introduced into the State through inter-State travel) or introduced from other States, according to the district health authorities.
The areas that reported confirmed cases between April 1 and June 13 included Alangad, Keezhmad, Munambam, Parakadavu, Mazhuvannoor, Edathala, Vazhakulam, Manjapra, Kalamassery, Vengoor, Ezhikkara, Kalamassery, Thripunitura, Kaloorkad, Kadavanthra, Koonamavu, Kothamangalam, Maradi, Pandappilli, Vennala, Cheurvattoor, and Puthrika.
Stating that Kerala is a low-prevalence area for malaria, Dr. Rajeev Jayadevan, convener, Research Cell of the Indian Medical Association, Kerala, pointed out that malaria was being reported in the State primarily due to imported disease.
'For instance, migrant workers from other parts of India, where malaria is endemic, come to Kerala in search of work. In addition, international travellers from Africa also bring cases of malaria. As it is not a common cause of fever in the region, the diagnosis can be missed if healthcare professionals are not specifically looking for it,' he said.
He said malaria must be suspected if the patient profile fits that of malaria, for instance, with travel history and clinical features such as fever, anaemia and jaundice. 'Testing will identify new pockets and help limit the spread. As mosquitoes spread the disease, vector control measures need to be carried out,' he said.
Dr. Ashadevi, District Medical Officer, said the cases had been mostly reported from areas that had significant presence of inter-State workers. 'We have increased the number of screening camps in such areas as part of the preventive measures initiated. Most of those diagnosed with the disease were asymptomatic,' she said.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Mint

17 hours ago

• Mint

Covid-19 now endemic in India, say government scientists as cases decline

New Delhi: Covid-19 has become endemic in India, top scientists at the Department of Biotechnology (DBT) monitoring the virus have said, ruling out the risk of any severe fresh outbreak. The current situation, they noted, is marked by small, isolated episodes rather than large waves of infections. This assessment is reflected in the steadily declining number of active cases. India's active caseload dropped to 5,012 on Sunday, down from 5,976 on Friday, according to official data. Two new deaths were recorded in the last 24 hours, taking the total fatalities this year to 112. Scientists attribute the decline to high population immunity and the continuing mildness of the virus. The current spread is largely driven by Omicron sub-variants NB.1.8.1 and LF.7, which have so far remained less virulent. 'When transmission efficiency increases, the peak comes faster and the decline is also faster,' said Dr Raman Gangakhedkar, national chair at the Indian Council of Medical Research (ICMR) and former head scientist at the agency. 'Covid-19 has become endemic in India. The concerning part is that we don't want new infections, but the good news is that new variants over the last three years have remained mild or milder.' He also noted that many infections now go undetected but still contribute to building antibody responses in the population, a natural form of immunization that limits severe illness. The testing levels have declined, and comprehensive data on current infections remains limited. 'Presently, there is no very good record of the number of tests being done, and it needs to be done scientifically. But there are no significant adverse clinical symptoms to be concerned about,' one senior DBT scientist said. Dr Rajeev Jayadevan, public health expert and past president of the Indian Medical Association (IMA), Cochin, said that Covid-19 is now behaving like a cyclical disease, with temporary immunity leading to periodic rises in cases. 'As the level of immunity in the population drops, the virus is able to infect more people and cases will naturally rise. However, due to past vaccination and exposure to the virus earlier, immune memory protects against severe disease and death,' he said. Vulnerable individuals, he added, should remain cautious, especially during periods of surge. Jayadevan also pointed out that SARS-CoV-2 continues to evolve in response to the human immune system, leading to recurring infection cycles roughly every 6 to 12 months. 'The reported number of cases is always an underestimate because of limited testing,' he said. Influenza, which is also circulating, remains a significant contributor to disease burden, he added. Earlier, Mint reported that a spike in cases during April was driven by the JN.1.16 sub-variant of Omicron. In May, most cases were linked to recombinant sub-lineages such as LF.7 and LP.8.1.2. As per government guidelines, all hospitalized Severe Acute Respiratory Illness (SARI) patients and 5% of Influenza Like Illness (ILI) cases continue to be tested for Covid-19. Positive SARI samples are routinely sent for genome sequencing. The health ministry reported 1,197 recoveries in the past 24 hours, bringing total recoveries this year to 19,435. Authorities continue to advise precautions, including avoiding crowded places when unwell and following Covid-appropriate behaviour. 'In hospitals too, patient load has come down and most cases are now manageable at home,' said Dr Vikas Maurya, head of the respiratory department at Fortis Hospital, Shalimar Bagh.

Hindustan Times

2 days ago

• Hindustan Times

Gurugram: 5 treatments under Ayushman scheme no longer available in pvt hospitals

Jun 21, 2025 05:54 AM IST Five major treatments under the Ayushman Bharat-Chirayu Yojana will no longer be available in private hospitals, according to new guidelines issued by the health department. They will be only available in government hospitals. Gurugram: 5 treatments under Ayushman scheme no longer available in pvt hospitals They are cataract surgery, hysterectomy (uterus operation), laparoscopic gall bladder surgery, treatment for vomiting and diarrhoea-related illnesses, and pulmonary disease. 'The government should have consulted stakeholders before implementing such a major decision. While public health must always be the top priority, the reality is that many government hospitals lack the infrastructure to provide some of these treatments in Haryana. This could lead to difficulties for patients,' said Dr Mahaveer Jain, state president of the Indian Medical Association (IMA). The Gurugram Civil Hospital has a dedicated Ayushman Centre to support patients under the scheme. At present, hospital authorities say there is no excessive burden. However, patient flow is likely to rise due to the withdrawal of services from private hospitals. 'Currently, there is no pressure on the hospital, but if the patient load increases due to the directive, we will expand facilities accordingly,' said Dr Lokveer, principal medical officer of the Civil Hospital.

Time of India

2 days ago

• Time of India

3rd Covid death: Ludhiana under the microscope.

Ludhiana: Local health authorities are ramping up Covid-19 testing and preparedness after the district recorded its third virus-related death on Thursday, raising concerns about rising cases and the vulnerability of those with underlying health conditions. An 82-year-old man from the Samrala Road area died at a private hospital near Sherpur Chowk, the health department has reported. Officials concerned have said that the patient, who had a history of cardiac problems, was admitted on June 15 and died of acute myocardial infarction (heart attack). A Covid-19 test conducted after his admission returned positive. The patient had no recent travel history, and his daughter, with whom he lived, has not exhibited symptoms. Civil surgeon Dr Ramandeep Kaur confirmed that all three Covid-19 deaths in the district involved patients with comorbidities, and two occurred at a hospital in Chandigarh. "We are geared up already to check Covid-19, and have issued advisories to the public," she said. Health department officials have directed ground staff to increase testing of suspected cases and to remain vigilant. Of the three reported Covid-19 victims, two were elderly and one was middle-aged, officials have said. Four patients are hospitalised currently: one is on intermittent oxygen support, two are stable without support, and one is a chronic kidney disease patient. As of Friday, Ludhiana has reported a total of 64 Covid-19 cases since the start of the recent wave, with four new cases confirmed on Friday. The latest cases include two males, aged 51 and 65, and two females, aged 42 and 63, all from urban areas. Also, 34 patients have completed home quarantine, while 27 remain active cases — 23 of whom are isolating at home. Medical experts are urging residents, those with existing health issues especially, to take extra precautions. Dr Dheeraj Aggarwal, president of the Ludhiana chapter of the Indian Medical Association, warned that people with comorbidities are at higher risk of infection and should avoid social gatherings, practise frequent hand washing, and maintain physical distance. He also recommended a nutritious diet during the monsoon season to help maintain immunity. MSID:: 121977194 413 |